Melanotan II.
About Melanotan II
Melanotan II is studied in dermatological and anti-aging research, e.g. in relation to skin and pigmentation models. MT-2 simultaneously activates multiple melanocortin receptors (MC1, MC3, MC4, MC5), which is why effects on pigmentation, appetite, and sexual function are described in parallel.
Research Application
Studied in research on pigmentation, appetite regulation, and sexual function, since it activates multiple melanocortin receptors simultaneously. Clinical development was discontinued before Phase 3 and never submitted for FDA approval.
Important to know
Claims circulating online are often not backed by valid clinical data. Treat all information as a starting point for your own scientific research, not as usage guidance.
Sequence and regulatory status data are based on publicly available sources and refer to the compound in general, not to a specific product.
Research Overview
The evidence base for skin and pigmentation peptides is largely based on preclinical and early clinical investigations.
- Dorr RT, et al. Life Sciences. 1996;58(20):1777–1784. PMID 8637402
- Wessells H, et al. J Urol. 1998;160(2):389–393. PMID 9679881
References without a PMID can be located via the respective publisher. This overview does not claim to be exhaustive.
Question about Melanotan II?
We reply personally – via email or Telegram.